Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 369

Related Citations for PubMed (Select 16600386)

1.

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.

Engwegen JY, Gast MC, Schellens JH, Beijnen JH.

Trends Pharmacol Sci. 2006 May;27(5):251-9. Epub 2006 Apr 4. Review.

PMID:
16600386
2.

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH.

Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Review.

PMID:
19082706
3.

[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].

Solassol J, Marin P, Maudelonde T, Mangé A.

Bull Cancer. 2005 Sep;92(9):763-8. Review. French.

PMID:
16203265
4.

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.

Seibert V, Ebert MP, Buschmann T.

Brief Funct Genomic Proteomic. 2005 May;4(1):16-26. Review.

5.

SELDI-TOF-MS proteomics of breast cancer.

Clarke CH, Buckley JA, Fung ET.

Clin Chem Lab Med. 2005;43(12):1314-20. Review.

PMID:
16309366
6.

SELDI-TOF serum proteomics and breast cancer: which perspective?

Garrisi VM, Abbate I, Quaranta M, Mangia A, Tommasi S, Paradiso A.

Expert Rev Proteomics. 2008 Dec;5(6):779-85. doi: 10.1586/14789450.5.6.779. Review.

PMID:
19086858
7.

[Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology].

Espejel F, Roa JC.

Med Clin (Barc). 2008 Sep 13;131(8):312-7. Review. Spanish.

PMID:
18803927
9.

SELDI-TOF proteomic analysis and cancer detection.

Henderson NA, Steele RJ.

Surgeon. 2005 Dec;3(6):383-90, 422. Review.

PMID:
16353858
10.

Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.

Bouamrani A, Ternier J, Ratel D, Benabid AL, Issartel JP, Brambilla E, Berger F.

Clin Chem. 2006 Nov;52(11):2103-6. Epub 2006 Sep 21.

11.

[Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].

Gonçalves A, Bertucci F, Birnbaum D, Borg JP.

Med Sci (Paris). 2007 Mar;23 Spec No 1:23-6. Review. French.

12.

Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.

Ricolleau G, Charbonnel C, Lodé L, Loussouarn D, Joalland MP, Bogumil R, Jourdain S, Minvielle S, Campone M, Déporte-Fety R, Campion L, Jézéquel P.

Proteomics. 2006 Mar;6(6):1963-75.

PMID:
16470659
13.

Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.

Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, Fadi E, Zambon CF, Bozzato D, Moz S, Seraglia R, Pedrazzoli S, Plebani M.

Clin Chem Lab Med. 2009;47(6):713-23. doi: 10.1515/CCLM.2009.158.

PMID:
19426140
14.

Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.

Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF 3rd, Liotta L.

Adv Exp Med Biol. 2003;532:59-68. Review.

PMID:
12908550
16.

SELDI-TOF-MS of saliva: methodology and pre-treatment effects.

Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):45-53. Epub 2006 Oct 27.

PMID:
17070117
17.

[Proteomics and breast cancer].

Mathelin C, Tomasetto C, Cromer A, Rio MC.

Gynecol Obstet Fertil. 2006 Dec;34(12):1161-9. Epub 2006 Nov 22. Review. French.

PMID:
17123853
18.
19.

Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.

El-Aneed A, Banoub J.

Anticancer Res. 2006 Sep-Oct;26(5A):3293-300. Review.

20.

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.

Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b.

PMID:
18391596
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk